Immune Support Tablets (Reese) – Unlisted Sodium (2017)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. Product is sold under the following brand names: Best Choice UPC 0 70038 60863 9 & UPC 0 70038 60863 9; Discount Drug Mart UPC 0 93351 00909 9; Freds Mart UPC 0 84579 12451 0; Good Neighbor Pharmacy UPC 0 87701 40672 0; Health Accents UPC 7 25439 95738 0; Health Mart UPC 0 52569 14073 4; Hyvee UPC 0 75450 06187 1; Kinray Preferred Plus UPC 0 23513 81512 1; Leader UPC 0 96295 13167 3 & UPC 0 96295 12239 8; Liv
Brand
Reese Pharmaceutical Company
Lot Codes / Batch Numbers
All lots
Products Sold
All lots
Reese Pharmaceutical Company is recalling Orange Flavor Immune Support Dietary Supplement Effervescent Tablets 10 Tablets/bottle. Product is s due to The label does not list "Sodium" in the ingredient statement.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The label does not list "Sodium" in the ingredient statement.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
AL, AZ, AR, CA, CO, CT, FL, GA, HI, ID, IL, IN, IA, KY, LA, ME, MD, MA, MI, MN, MS, MO, NE, NJ, NY, NC, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, WI, WY
Page updated: Jan 6, 2026